July, 2025

article thumbnail

Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations

Drug Topics

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Vaccines 520
article thumbnail

Pricing watchdog will take on the rising cost of drugs at launch

PharmaVoice

ICER’s upcoming report could shed light on how the launch price of newly approved drugs affects overall cost and access from a patient perspective.

226
226
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Latest analysis from Ohio exposes growing abuses of the 340B markup program

PhRMA

Some Ohio hospitals are exploiting the little-known federal 340B program to boost their profits at the expense of patients, taxpayers and employers, according to recent reporting from the Ohio Capital Journal (OCJ).

Hospitals 185
article thumbnail

FDA Approves Linvoseltamab-Gcpt for Treatment of Relapsed or Refractory Multiple Myeloma

Pharmacy Times

The treatment becomes the first approved BCMAxCD3 bispecific antibody with the potential to achieve biweekly or monthly dosing in patients with relapsed/refractory multiple myeloma.

FDA 155
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Child walks again after receiving experimental treatment for rare genetic condition

STAT

In what experts are calling a “dream come true,” scientists used a recent biochemical discovery to help an 8-year-old boy with a rare genetic condition regain mobility. Researchers from NYU Langone demonstrated, in a study published in Nature on Wednesday , how a chemical precursor to a commonly available enzyme, CoQ10, can help brain cells overcome a rare genetic condition that severely hobbles cells’ energy production process.

140
140
article thumbnail

Strategies for digital success in hospital pharmacy

Hospital Pharmacy Europe

With the impact of digital technologies on healthcare provision and the workforce ramping up, Matthew Spence, clinical digital lead for medicines management and pharmacy services at Leeds Teaching Hospitals NHS Trust, offers practical tips and strategies based on insights and initiatives from his own hospital to support pharmacy teams in navigating digital transformation.

More Trending

article thumbnail

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Vaccines 179
article thumbnail

What anti-inflammatory can you take with Xarelto?

The Checkup by Singlecare

Xarelto is the brand name for rivaroxaban, an anticoagulant (blood thinner). It’s a factor Xa inhibitor , which helps decrease blood clot production in the body. Xarelto is FDA-approved to prevent and treat clots in numerous conditions, such as stroke, nonvalvular atrial fibrillation, and deep vein thrombosis. Unfortunately, combining Xarelto with most common anti-inflammatory medications is not safe, because it can increase your risk of bleeding.

FDA 97
article thumbnail

Experts Weigh In on What FDA's Removal of REMS for CAR T Means for Patients, Pharmacists

Pharmacy Times

Debra Patt, MD, PhD, MBA, and Houston Holmes, MD, discuss the ramifications of the FDA's removal of REMS requirements for approved chimeric antigen receptor (CAR) T-cell (CAR T) therapies.

FDA 116
article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a new dosing regimen of the drug with an improved safety profile.

FDA 88
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Why this activist is putting her body on the line for Americans with disabilities

STAT

Flanked by her friends as lawmakers debated the future of a 60-year-old health care plan, Latoya Maddox raised her voice, shouting, “No cuts to Medicaid! No cuts to Medicaid!” The chanting, during a meeting of the House Energy and Commerce Committee on May 13, quickly earned her and her fellow disabled activists in the room a rough escort out by Capitol Police.

99
article thumbnail

Pharmacist-Led Telephonic Insulin Titration Significantly Improved A1C

Drug Topics

Researchers explored the effectiveness of telephonic insulin titration by a clinical pharmacist compared with in-office titration among patients in a medical residency clinic.

469
469
article thumbnail

Need a DTC platform? Here’s how one company built its own.

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Insurance 130
article thumbnail

FDA approves first-of-a-kind oral therapy for rare disease

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved the first oral on-demand therapy for acute attacks of hereditary angioedema (HAE) in individuals aged 12 years and older. This rare genetic disease leads to tissue swelling attacks in the body that can be life-threatening. It is caused by a deficiency or dysfunction in the C1 esterase inhibitor (C1INH) protein and subsequent uncontrolled activation of the kallikrein-kinin system, KalVista Pharmaceuticals shared.

FDA 97
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Sunvozertinib Approved by FDA as Oral Treatment of NSCLC With EGFR Exon 20 Insertion Mutations

Pharmacy Times

Sunvozertinib becomes the first and only targeted approval treatment for patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 20 insertion mutations.

FDA 130
article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

Chinese regulators have approved four new drugs developed by local biopharma companies, including a first-of-its-kind molecule in blood cancer.

101
101
article thumbnail

STAT+: The growing influence of vaccine skeptics inside HHS

STAT

WASHINGTON — Robert F. Kennedy Jr. spent much of his confirmation process before becoming the nation’s health secretary reassuring lawmakers that he would not undermine public confidence in vaccines and seeking to distance himself from the anti-vaccine group he founded, Children’s Health Defense. As health secretary, he has installed former prominent members of that group and other vaccine skeptics in positions at the department he runs or agencies it oversees.

Vaccines 137
article thumbnail

Financial Planning Remains Core Focus to Create Thriving Pharmacy Business | McKesson ideaShare

Drug Topics

Pharmacists can transform from only being prescription dispensers to health care hubs that offer comprehensive patient care and generate innovative revenue streams.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

A biopharma doubles down on diversity goals through a newly created position

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

FDA 130
article thumbnail

Boehringer raises hope of oral drug for diabetic eye disease

pharmaphorum

Boehringer has started a phase 2 trial of an oral therapy that could help people with diabetic macular oedema avoid regular injections into the eye

94
article thumbnail

McKesson ideaShare 2025 Unveils Robust Education Tracks to Empower Independent Pharmacies

Pharmacy Times

The conference offers immersive, peer-driven education tracks designed to help independent pharmacies innovate, adapt, and thrive in a changing health care landscape.

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

Novartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are infected with malaria. The nod is for a new formulation of Coartem, which is also known commercially in come countries as Riamet.

92
article thumbnail

Does Mounjaro cause constipation?

The Checkup by Singlecare

Mounjaro , a brand-name version of tirzepatide , is a once-weekly injectable medication that targets both GIP and GLP-1 receptors. It’s designed to help manage blood sugar in adults with Type 2 diabetes when combined with diet and exercise. While many users report weight loss, it’s important to note that Mounjaro is FDA approved only for diabetes treatment.

FDA 99
article thumbnail

GLP-1s Effective as Adjunctive Therapy in Patients with T1D, Obesity | ADA 2025

Drug Topics

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

article thumbnail

The MEK effect on cancer — a slow and steady approach to drug resistance

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

article thumbnail

Leading medical groups sue Kennedy over changed Covid-19 vaccine recommendations

STAT

WASHINGTON — Six major medical groups, and a pregnant physician, are suing health secretary Robert F. Kennedy Jr. over changes he made to Covid-19 vaccine recommendations that they say were unlawful and undermine public trust in health care. The suit argues that a May 19 directive signed by Kennedy, which said that the Covid-19 vaccine would no longer be recommended for healthy children and pregnant people , violates decades of policy governing how vaccines are reviewed, approved, an

Vaccines 145
article thumbnail

When Less Is More: Addressing Polypharmacy in High-Risk Populations

Pharmacy Times

Andrew E. Esch, MD, MBA, discusses the need for systemic reforms to support pharmacist-led medication optimization in palliative and community-based care.

108
108
article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

In a quarterly update, the FDA said it’s evaluating the need for regulatory action on argenx’s Vyvgart Hytrulo after observing a potential signal of “severe worsening” of CIDP. But analysts are brushing off the risk.

FDA 103
article thumbnail

New medicine access times to be slashed under NHS plan

pharmaphorum

Reports suggest a new framework for medicine reviews and a push to reduce NHS reliance on overseas-trained staff will feature in the 10-year plan.

97
article thumbnail

Pharmacy Schools Should Prepare Students for Workforce Challenges

Drug Topics

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

article thumbnail

GLP-1 roadblocks: Discontinuation rates soar as insurers clamp down

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Insurance 130
article thumbnail

Patients with ultra-rare diseases worry new FDA rules will leave them without treatment

The Guardian - Pharmaceutical Industry

Testing is difficult for drugs for rare diseases, and new rules may make it harder for sufferers to obtain life-saving drugs US drug regulators have increasingly signaled a focus on faster approvals and rare diseases, but patients with ultra-rare ailments fear they are falling through the cracks, especially given challenges to conducting clinical trials.

FDA 81
article thumbnail

Study Links Specific Hormone Therapies to Breast Cancer Risk in Younger Women

Pharmacy Times

Research reveals a link between estrogen plus progestin hormone therapy and increased breast cancer risk in young women, urging personalized treatment approaches.

114
114